Geron Corp
NASDAQ:GERN
$2.05
-$0.02
(-0.97%)
Quote as of 4:00 PM EST on 02/09/12
Related Resources
GERN
vs. S&P 500
|
$2.05
-$0.02
(-0.97%)
|
|
| Today's Open | $2.09 |
|---|---|
| Previous Close | $2.07 |
| Daily Range | $2.04 - $2.09 |
| 52-Week Range | $1.35 - $5.24 |
| Market Cap | $269.52M |
| P/E Ratio | -1.85 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 463,175 |
| Average Daily Volume | 1,334,966 |
| Current FY EPS | -$0.72 |
GERN Information
| Description |
|---|
| A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
2/7/2012 by DailyFinance
Don't Bet Against This Biotech IPO
1/31/2012 by DailyFinance
Has GlaxoSmithKline Become the Perfect Stock?
1/27/2012 by DailyFinance
1/20/2012 by DailyFinance
1/15/2012 by DailyFinance
The Worst Health Care Stocks of 2011
12/30/2011 by DailyFinance
Bullish Ideas: Short-Sellers Think These Cash-Rich Companies Have More Upside
12/28/2011 by DailyFinance
Geron's Hurry-Up-and-Wait Strategy
12/23/2011 by DailyFinance
Health Care's Worst Stocks 2011: Dendreon
12/23/2011 by DailyFinance
Whoa! My Stock Just Whupped the Market!
12/21/2011 by DailyFinance
